-
101
The Relationship Between the Modulation of Intestinal Microbiota and the Response to Immunotherapy in Patients with Cancer
Published 2025-01-01Subjects: “…immunotherapy…”
Get full text
Article -
102
Innovative applications and future trends of multiparametric PET in the assessment of immunotherapy efficacy
Published 2025-01-01Subjects: Get full text
Article -
103
Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
104
Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma?
Published 2012-01-01“…The therapeutic options remain limited for advanced MM, and those directed to the neoplastic cells have not brought major survival advantage so far. Immunotherapy is another targeted option. Ipilimumab, a monoclonal antibody directed to CTLA-4 present on cytotoxic T cells boosts immunity, particularly its anti-MM activity. …”
Get full text
Article -
105
Response of Immunotherapy to Tumour-TICLs Interactions: A Travelling Wave Analysis
Published 2014-01-01“…We present a travelling wave analysis of a tumour-immune interaction model with immunotherapy. We use the geometric treatment of an apt-phase space to establish the intersection between stable and unstable manifolds. …”
Get full text
Article -
106
The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer
Published 2024-09-01Subjects: Get full text
Article -
107
Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination
Published 2015-01-01“…In this review, we describe a process, which integrates next generation sequencing based cancer mutanome mapping, in silico target selection and prioritization approaches, and mRNA vaccine manufacturing and delivery into a process we refer to as MERIT (mutanome engineered RNA immunotherapy).…”
Get full text
Article -
108
Emerging insights into intravital imaging, unraveling its role in cancer immunotherapy
Published 2025-02-01Subjects: Get full text
Article -
109
Differences in expression profiles in malingant melanoma patients according to immunotherapy response
Published 2018-01-01Subjects: Get full text
Article -
110
Immunological differences between monophasic and biphasic synovial sarcoma with implications for immunotherapy
Published 2024-12-01Subjects: Get full text
Article -
111
An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers
Published 2025-02-01Subjects: Get full text
Article -
112
Utilizing Cytokines to Function-Enable Human NK Cells for the Immunotherapy of Cancer
Published 2014-01-01“…In the future, such strategies will be combined with negative regulatory signal blockade and enhanced recognition to comprehensively enhance NK cells for immunotherapy.…”
Get full text
Article -
113
Harnessing dendritic cells for pancreatic cancer immunotherapy: a novel promising approach
Published 2025-01-01Get full text
Article -
114
Lymphatic-derived oxysterols promote anti-tumor immunity and response to immunotherapy in melanoma
Published 2025-01-01“…However, it also potentiates immunotherapy by supporting immune cell trafficking. …”
Get full text
Article -
115
Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy
Published 2021-01-01“…Cancer immunotherapy, which reactivates weakened immune cells of cancer patients, has yielded great success in recent years. …”
Get full text
Article -
116
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
Published 2019-01-01“…Lung cancer is one of the deadliest and most common malignancies in the world, representing one of the greatest challenges in cancer treatment. Immunotherapy is rapidly changing standard treatment schedule and outcomes for patients with advanced malignancies. …”
Get full text
Article -
117
Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy
Published 2025-02-01Subjects: Get full text
Article -
118
Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy
Published 2025-02-01Subjects: “…ICI Immunotherapy…”
Get full text
Article -
119
Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
Published 2022-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
120
A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy
Published 2014-01-01“…Immunotherapy emerged as a promising therapeutic approach to highly incurable malignant gliomas due to tumor-specific cytotoxicity, minimal side effect, and a durable antitumor effect by memory T cells. …”
Get full text
Article